In situ genetic modification of gut bacteria
Abstract
The crucial role of the gut microbiome in human health has driven a need to understand bacterial function within their complex native ecosystem. However, traditional functional genomic methods require isolating, cultivating, and modifying bacteria in vitro before their reintroduction in vivo. This process often necessitates the use of axenic animals or antibiotic treatments, creating artificial conditions that disrupt key microbial interactions and can obscure relevant phenotypes. This review highlights emerging tools for precise, in situ genetic manipulation of bacteria directly within the gut. We cover diverse technologies, including DNA delivery systems (e.g. engineered temperate phages, phagemids, and conjugative plasmids), and genetic perturbation strategies (e.g. CRISPR-Cas tools and transposons). These methods offer the opportunity to engineer unculturable microbes in their natural habitat and conduct genetic screens to investigate the role of specific genes and pathways. Finally, we explore the potential therapeutic applications of in situ microbiome editing.
Related
- In situ-activated engineered bacteria release combined dual-therapeutic proteins for tumor immunotherapy
- A simple platform for in situ DNA-PAINT optimization enables improved multiplexed super-resolution imaging in Gram-negative bacteria
- In Situ Fusarium Mycotoxin Mitigation During Wholegrain Wheat Flour Fermentation with Sourdough Lactic Acid Bacteria and Further Insights into Reduction Mechanisms.
- Engineering Persistent and Rewritable Genetic Memory in Bacteria through Multiscale Plasmid Competition
- Language-Model-Based Detection of Genetic Editing in Bacteria
BibTeX
@article{maire2026situ,
title = {{In situ genetic modification of gut bacteria}},
author = {Amandine Maire and Raphaël Laurenceau and Nathalie Rolhion and David Bikard},
journal = {Current Opinion in Microbiology},
year = {2026},
month = nov,
doi = {10.1016/j.mib.2026.102766},
url = {https://hal.science/hal-05856648v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - In situ genetic modification of gut bacteria
AU - Amandine Maire
AU - Raphaël Laurenceau
AU - Nathalie Rolhion
AU - David Bikard
PY - 2026
DA - 2026/11/09
JO - Current Opinion in Microbiology
DO - 10.1016/j.mib.2026.102766
UR - https://hal.science/hal-05856648v1
AB - The crucial role of the gut microbiome in human health has driven a need to understand bacterial function within their complex native ecosystem. However, traditional functional genomic methods require isolating, cultivating, and modifying bacteria in vitro before their reintroduction in vivo. This process often necessitates the use of axenic animals or antibiotic treatments, creating artificial conditions that disrupt key microbial interactions and can obscure relevant phenotypes. This review highlights emerging tools for precise, in situ genetic manipulation of bacteria directly within the gut. We cover diverse technologies, including DNA delivery systems (e.g. engineered temperate phages, phagemids, and conjugative plasmids), and genetic perturbation strategies (e.g. CRISPR-Cas tools and transposons). These methods offer the opportunity to engineer unculturable microbes in their natural habitat and conduct genetic screens to investigate the role of specific genes and pathways. Finally, we explore the potential therapeutic applications of in situ microbiome editing.
SN - 1369-5274
SN - 1369-5274
ER -